New approaches to the therapy of acute respiratory infections in children with chronic ENT-pathology

We have evaluated efficacy of Stomatidin (hexetidine) and Lizobakt in the treatment of acute respiratory infections in frequently ill children and children with chronic ENT pathology. It was found that the inclusion of Stomatidin in complex therapy within the first days of the disease provides a reduction of terms of relief of major symptoms of the disease (intoxication, local manifestations of oropharyngeal lesions). Late in the early convalescence period, the Lizobakt administration promotes the normalization of the immune homeostasis of the oral cavity and, indirectly, the correction of the microflora of this epitope, and increase of colonization resistance.

frequently ill children, acute respiratory infections, Stomatidin, Lizobakt